Drug class
Antiseizure medicine; voltage-gated sodium-channel modulator and positive allosteric GABAA receptor modulator
Mechanism of action
Reduces repetitive neuronal firing by inhibiting persistent sodium currents and can enhance inhibitory signalling through positive allosteric modulation of GABAA receptors. The relative contribution of these actions to clinical antiseizure effects is not fully defined.
General use cases
- Treatment of partial-onset (focal) seizures in adults; use requires gradual dose titration because of serious hypersensitivity and other safety risks
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
